Verastem Correlations
| VSTM Stock | USD 5.70 0.23 3.88% |
The current 90-days correlation between Verastem and Regenxbio is 0.42 (i.e., Very weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Verastem moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Verastem moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Verastem Correlation With Market
Pay attention - limited upside
The correlation between Verastem and DJI is -0.79 (i.e., Pay attention - limited upside) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Verastem and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Verastem Stock
| 0.69 | OSE | OSE Pharma SA | PairCorr |
| 0.62 | RAC | Race Oncology | PairCorr |
| 0.74 | VCYT | Veracyte Earnings Call Tomorrow | PairCorr |
| 0.76 | DRMA | Dermata Therapeutics | PairCorr |
| 0.93 | DTIL | Precision BioSciences | PairCorr |
Moving against Verastem Stock
| 0.78 | GXEA | Galapagos NV | PairCorr |
| 0.77 | EQ | Equillium | PairCorr |
| 0.72 | 8VP1 | AVRICORE HEALTH INC | PairCorr |
| 0.62 | VALN | Valneva SE ADR | PairCorr |
| 0.54 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.36 | 2CG | NANOSPHERE HEASCIENCES | PairCorr |
| 0.34 | CMB | Cambium Bio Earnings Call Tomorrow | PairCorr |
| 0.33 | DNLI | Denali Therapeutics Earnings Call This Week | PairCorr |
| 0.9 | DRTS | Alpha Tau Medical | PairCorr |
| 0.88 | 0P6S | Bayer AG NA | PairCorr |
| 0.77 | 6C1 | CytomX Therapeutics | PairCorr |
| 0.56 | DSGN | Design Therapeutics | PairCorr |
| 0.48 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.42 | VERA | Vera Therapeutics | PairCorr |
| 0.37 | AVH | Avita Medical | PairCorr |
| 0.35 | PYC | Physiomics Plc | PairCorr |
| 0.31 | SAB | Sonic Healthcare | PairCorr |
| 0.78 | DVAX | Dynavax Technologies | PairCorr |
| 0.71 | SRZNW | Surrozen Warrant | PairCorr |
| 0.7 | VNDA | Vanda Pharmaceuticals Trending | PairCorr |
| 0.62 | ALA | Arovella Therapeutics Earnings Call Tomorrow | PairCorr |
| 0.52 | HDP1 | Arrowhead Pharmaceuticals | PairCorr |
| 0.36 | NANO | Nanobiotix SA | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Verastem Stock performing well and Verastem Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Verastem's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| RGNX | 3.69 | (0.46) | 0.00 | (0.33) | 0.00 | 7.94 | 27.87 | |||
| ABSI | 3.82 | (0.15) | (0.01) | 0.00 | 5.31 | 8.58 | 27.80 | |||
| MLTX | 3.77 | 0.65 | 0.16 | 0.70 | 3.68 | 11.10 | 35.46 | |||
| KALV | 2.94 | 0.05 | 0.02 | 0.10 | 3.79 | 6.17 | 20.72 | |||
| PRTA | 2.15 | (0.25) | 0.00 | (0.10) | 0.00 | 5.10 | 14.00 | |||
| VTYX | 3.28 | 0.79 | 0.17 | (3.65) | 3.14 | 9.00 | 37.04 | |||
| OLMA | 6.21 | 2.66 | 0.60 | (0.76) | 2.87 | 9.82 | 145.73 | |||
| FDMT | 3.73 | (0.11) | 0.00 | (0.06) | 0.00 | 7.15 | 27.09 | |||
| GOSS | 5.00 | (1.88) | 0.00 | (0.41) | 0.00 | 7.66 | 27.11 | |||
| CRVS | 6.56 | 2.54 | 0.47 | (0.32) | 3.40 | 7.35 | 174.42 |
Verastem Corporate Management
| Jonathan Pachter | Chief Officer | Profile | |
| Michael Crowther | Chief Officer | Profile | |
| Sean Flynn | Gen VP | Profile | |
| MD MSc | Head Strategy | Profile | |
| Robert Weinberg | CoFounder Board | Profile | |
| Daniel Calkins | Interim Officer | Profile |